» Articles » PMID: 12590976

Characterization of Monoclonal Antibodies Recognizing HLA-G or HLA-E: New Tools to Analyze the Expression of Nonclassical HLA Class I Molecules

Abstract

Nonclassical major histocompatibility complex (MHC) class I human leukocyte antigen E (HLA-E) and HLA-G molecules differ from classical ones by specific patterns of transcription, protein expression, and immunotolerant functions. The HLA-G molecule can be expressed as four membrane-bound (HLA-G1 to -G4) and three soluble (HLA-G5 to -G7) proteins upon alternative splicing of its primary transcript. In this study, we describe a new set of monoclonal antibodies (mAbs) called MEM-G/01, -G/04, -G/09, -G/13, MEM-E/02, and -E/06 recognizing HLA-G or HLA-E. The pattern of reactivity of these mAbs were analyzed on transfected cells by flow cytometry, Western blotting, and immunochemistry. MEM-G/09 and -G/13 mAbs react exclusively with native HLA-G1 molecules, as the 87G mAb. MEM-G/01 recognizes (similar to the 4H84 mAb) the denatured HLA-G heavy chain of all isoforms, whereas MEM-G/04 recognizes selectively denatured HLA-G1, -G2, and -G5 isoforms. MEM-E/02 and -E/06 mAbs bind the denatured and cell surface HLA-E molecules, respectively. These mAbs were then used to analyze the expression of HLA-G and HLA-E on freshly isolated cytotrophoblast cells, on the JEG-3 placental tumor cell line, and on cryopreserved and paraffin-embedded serial sections of trophoblast tissue. These new mAbs represent valuable tools to study the expression of HLA-G and HLA-E molecules in cells and tissues under normal and pathologic conditions.

Citing Articles

Conformational Alterations of the Cell Surface of Monomeric and Dimeric β2m-Free HLA-I (Proto-HLA) May Enable Novel Immune Functions in Health and Disease.

Ravindranath M, Ravindranath N, Amato-Menker C, Hilali F, Filippone E Curr Issues Mol Biol. 2024; 46(7):6961-6985.

PMID: 39057057 PMC: 11276036. DOI: 10.3390/cimb46070416.


Diversity in the HLA-I Recognition of HLA-F Monoclonal Antibodies: HLA-F or HLA-Ib Monospecific, HLA-E or HLA-G Bispecific Antibodies with or without HLA-Ia Reactivity.

Ravindranath M, Ravindranath N, Amato-Menker C, Hilali F, Filippone E Antibodies (Basel). 2024; 13(1).

PMID: 38390869 PMC: 10885067. DOI: 10.3390/antib13010008.


Unveiling the Immunogenicity of Ovarian Tumors as the Crucial Catalyst for Therapeutic Success.

Rodriguez G, Yakubovich E, Vanderhyden B Cancers (Basel). 2023; 15(23).

PMID: 38067396 PMC: 10705691. DOI: 10.3390/cancers15235694.


Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA?.

Ravindranath M, Ravindranath N, Selvan S, Hilali F, Amato-Menker C, Filippone E Biomolecules. 2023; 13(8).

PMID: 37627243 PMC: 10452486. DOI: 10.3390/biom13081178.


Antibodies for β2-Microglobulin and the Heavy Chains of HLA-E, HLA-F, and HLA-G Reflect the HLA-Variants on Activated Immune Cells and Phases of Disease Progression in Rheumatoid Arthritis Patients under Treatment.

Ravindranath M, Ravindranath N, Amato-Menker C, Hilali F, Selvan S, Filippone E Antibodies (Basel). 2023; 12(2).

PMID: 37092447 PMC: 10123671. DOI: 10.3390/antib12020026.